Ahoy, Mateys! Well, I’ve alternated between being anxious to write this, after my appointment a week ago, to the present, when it’s not so much fun. A week ago, all of the blood reports which were ba… more →
Log of the Optimistwrote 3 months ago: Ahoy, Mateys! Well, I’ve alternated between being anxious to write this, after my appointment a week … more →
wrote 5 months ago: Ahoy! Well, the FedEx guy has delivered the “Poison pills” for the next 3 weeks and I’m loaded with … more →
wrote 5 months ago: Ahoy Mateys! Anchors aweigh! Tomorrow morning the gangplank comes up and we’re off on our new voyage … more →
wrote 6 months ago: A great post from Michael McCaughan at the In Vivo Blog walks through the very complicated interacti … more →
wrote 11 months ago: Celgene International Sarl (NASDAQ: CELG) reported that results of a Phase I study combining REVLIMI … more →
wrote 1 year ago: Millenium Pharmaceuticals (NASDAQ:MLNM) is a new favorite among Wall Street Analysts. The favorabl … more →
wrote 2 years ago: The American Society of Clinical Oncology (ASCO) conducted its annual independant review and publish … more →
wrote 2 years ago: Some interesting oncology results: Millennium’s Velcade used in combo therapy for multiple mye … more →
wrote 2 years ago: Glaxo buying Reliant - GlaxoSmithKline Plc has agreed to buy privately held heart drug specialist Re … more →